HNF1A-MODY has age-dependent high penetrance; almost 63% of the patients with HNF1A mutations develop symptoms by the age of 25, 93.6% by the age of 50 years, and 98.7% by the age of 75 years [21,22]. The gene discussed is HNF1A; the disease is MODY.